Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone

The gold standard for prostate cancer (PCa) diagnosis is prostate biopsy. However, it remines controversial as an invasive mean for patients with PSA levels in the gray zone (4–10 ng/mL). This study aimed to develop strategy to reduce the unnecessary prostate biopsy. We retrospectively identified 23...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junxiao, Dong, Biao, Qu, Wugong, Wang, Jiange, Xu, Yue, Yu, Shuanbao, Zhang, Xuepei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083895/
https://www.ncbi.nlm.nih.gov/pubmed/32198373
http://dx.doi.org/10.1038/s41598-020-62015-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083895/
https://www.ncbi.nlm.nih.gov/pubmed/32198373
http://dx.doi.org/10.1038/s41598-020-62015-w

Ejemplares similares